Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another perspective
While I am not as Zenlike as ease2002 about the fact that S & L is selling. I do realize that they do want to reduce their risk exposure. Think about it, at on time with warrants and stock they controlled about 150 million shares (my estimate) I think that someday they will be satisfied with their risk exposure, stop or reduce selling and be in it (to quote Mr Swartz from the 2006 SHM) "for the long haul". Then, when the MMs don't have an offer to lean on, we may see some upside.


Share
New Message
Please login to post a reply